title: Platelet-dependent thrombin generation after in vitro fibrinolytic treatment.
abstract: BACKGROUND
  Fibrinolytic therapy is associated with frequent rethrombosis. There is evidence of both increased coagulation and platelet activation.
  
  
  RESULTS
  Platelet-rich plasma (PRP) or washed platelets were incubated with the fibrinolytic agents urokinase, recombinant tissue-type plasminogen activator (rt-PA), or plasmin at concentrations consistent with those in the plasma of patients treated for myocardial infarction. All of the fibrinolytic agents induced a more rapid generation of thrombin and decreased the clotting times of non-contact-activated PRP than in untreated PRP. This effect was not blocked by the inclusion of thrombin inhibitors during the fibrinolytic treatment. Washed platelets derived from rt-PA-treated PRP induced more rapid thrombin generation when resuspended in untreated plasma or treated plasma. Washed platelets were treated with plasmin, rt-PA, and urokinase and added to platelet-poor plasma. Platelets treated with either plasmin or rt-PA increased the ability of washed platelets to support thrombin generation, but urokinase was without significant effect.
  
  
  CONCLUSIONS
  These results indicate not only that plasmin can cause increased platelet support of prothrombin activation but also that rt-PA in the absence of plasminogen can have a direct effect on the platelet, which increases thrombin generation.
authors.affiliation: George Washington University Medical Center, Washington, D.C. 20037.
authors.forename: D L
authors.initials: DL
authors.lastname: Aronson
authors.forename: P
authors.initials: P
authors.lastname: Chang
authors.forename: C M
authors.initials: CM
authors.lastname: Kessler
mesh_terms: D001792:Blood Platelets / Q000502:physiology*; D005341:Fibrinolysin / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D010960:Plasminogen Activators / Q000494:pharmacology; D011994:Recombinant Proteins; D013917:Thrombin / Q000032:analysis / Q000096:biosynthesis*; D010959:Tissue Plasminogen Activator / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010960:Plasminogen Activators; D013917:Thrombin; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator